Can the biomolecular corona induce an allergic reaction?—A proof-of-concept study

Ferumoxytol nanoparticles are being used clinically for the treatment of anemia and molecular imaging in patients. It is well documented that while most patients tolerate ferumoxytol well, a small percentage of patients (i.e., 0.01%) develop severe allergic reactions. The purpose of our proof-of-con...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biointerphases
Main Authors: Muehe, Anne, Nejadnik, Hossein, Muehe, Henrik, Rosenberg, Jarrett, Gharibi, Hassan, Saei, Amir Ata, Lyu, Shu-Chen, Nadeau, Kari C., Mahmoudi, Morteza, Daldrup-Link, Heike E.
Format: Artigo
Jezik:Inglês
Izdano: American Vacuum Society 2021
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7861880/
https://ncbi.nlm.nih.gov/pubmed/33706522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1116/6.0000755
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki